We’re leaving our $105 fair value estimate and wide moat rating for Henry Schein unchanged after the company’s fourth-quarter results met our expectations. Excluding seasonal differences from the flu and
Henry Schein , Inc. ( HSIC ): EPS of $1.43 beats by $0.03 . Revenue of $2.53B (+5.4% Y/Y) in-line. Press Release Post your comment!
discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Wednesday January 29. Bullish Calls: Henry Schein ( HSIC ): "No one got hurt taking a profit, but management told an unbelievable story. I'm all in and I'm not
term shareholder interests. Henry Schein distributes health care products ..... operating and financial risk at Henry Schein is limited. Schein's scale helps ..... raising our fair value estimate for Henry Schein to $105 per share from $99 thanks
thanks to pent-up demand, in our view. However, Patterson's growth continues to that of its main competitor, Henry Schein , in the U.S. dental market, which also suggests Patterson might be yielding potential market share gains from smaller
We don’t plan to change our $99 fair value estimate for Henry Schein , as the company remains on track to meet our year-end expectations after its third-quarter results. Additionally, our 2014
We have upgraded Henry Schein HSIC and Patterson Companies PDCO to wide-moat companies thanks to their strong competitive advantages in the dental and veterinary
We have upgraded Henry Schein HSIC and Patterson PDCO to wide-moat companies thanks to their strong competitive advantages in the dental and veterinary distribution
We plan to raise our fair value estimate for Henry Schein HSIC as we transfer coverage to a new analyst. In the first quarter, Schein reported 9.3% revenue growth, which includes
integration features that VetStreet may not have. With VCA Antech and Idexx aggressively pushing their pet owner portals, we think the smaller portals offered by vet distributors like Henry Schein HSIC and Patterson PDCO could get squeezed out.